Skip to main content

Advertisement

Table 6 Stepwise multiple regression analysis of the change in HbA1c levels in relation to explanatory variables

From: Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study

Explanatory variable Regression coefficient SE t- value p-value
Baseline HbA1c (%) -0.489 0.015 -31.79 < 0.001
Baseline BMI (kg/m2) 0.016 0.006 2.70 0.007
Diabetes drug administration 0.176 0.049 3.59 < 0.001
Change rate in TG (%) 0.004 0.001 6.34 < 0.001
Change rate in TC (%) 0.005 0.001 4.13 < 0.001
Change rate in HDL-C (%) -0.002 0.001 -1.72 0.085
  1. R2 = 0.3884. Each estimated value indicates the influence in HbA1c per 1 unit change in each variable. The estimated values of diabetes-drug administration indicate the rates of influence in patients with and without drug